Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation

Journal of Neurochemistry

Volumn 87, Issue 3, 2003, Pages 709-721

  Rite, Inmaculada ^a   Venero, José L ^a   Tomás Camardiel, Mayka ^a   Machado, Alberto ^a   Cano, Josefina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Kainic acid; Neurotrophins; Nigrostriatal system; Quinolinic acid; Striatum.

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COLCHICINE; EXCITOTOXIN; GLUTAMATE DECARBOXYLASE; KAINIC ACID; MESSENGER RNA; NEUROTOXIN; PROTEIN C FOS; QUINOLINIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FOREBRAIN; GENE EXPRESSION REGULATION; GENE INDUCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MARKER GENE; NERVE CONDUCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TARGET CELL; TISSUE LEVEL;

ANIMALS; AXONAL TRANSPORT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; COLCHICINE; FEMALE; KAINIC ACID; MEDIAL FOREBRAIN BUNDLE; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTOXINS; QUINOLINIC ACID; RATS; RATS, WISTAR; RECEPTOR, TRKB; RNA, MESSENGER; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; UP-REGULATION;

ANIMALIA;

EID: 0142241354     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02041.x     Document Type: Article

References (61)

1. Alexander G. E. and Crutcher M. D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266-271.
2. Aliaga E., Rage F., Tapia-Arancibia L. and Bustos G. (1999) Negative regulation of brain-derived neurotrophic factor mRNA expression by kainic acid in substantia nigra. Brain Res. Mol. Brain Res. 71, 341-344.
3. Altar C. A. and DiStefano P. S. (1998) Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21, 433-437.
4. Altar C. A., Siuciak J. A., Wright P., Ip N. Y., Lindsay R. M. and Wiegand S. J. (1994) In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. Eur. J. Neurosci. 6, 1389-1405.
5. Altar C. A., Cai N., Bliven T., Juhasz M., Conner J. M., Acheson A. L., Lindsay R. M. and Wiegand S. J. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860.
6. Barbacid M. (1995) Structural and functional properties of the TRK family of neurotrophin receptors. Ann. N. Y. Acad. Sci. 766, 442-458.
7. von Bartheld C. S., Williams R., Lefcort F., Clary D. O., Reichardt L. F. and Bothwell M. (1996) Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors. J. Neurosci. 16, 2995-3008.
8. von Bartheld C. S., Wang X. and Butowt R. (2001) Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol. Neurobiol. 24, 1-28.
9. Batchelor P. E., Liberatore G. T., Wong J. Y., Porritt M. J., Frerichs F., Donnan G. A. and Howells D. W. (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived nurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19, 1708-1716.
10. Batchelor P. E., Porritt M. J., Martinelio P., Parish C. C., Liberatore G. T., Donnan G. A. and Howells D. W. (2002) Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell. Neurosci. 21, 436-453.
11. Bemelmans A. P., Horellou P., Pradier L., Brunet I., Colin P. and Mallet J. (1999) Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum. Gene Ther. 10, 2987-2997.
12. Blochl A. and Thoenen H. (1995) Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur. J. Neurosci. 7, 1220-1228.
13. Blochl A. and Thoenen H. (1996) Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons. Mol. Cell Neurosci. 7, 173-190.
14. Caleo M., Menna E., Chierzi S., Cenni M. C. and Maffei L. (2000) Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system. Curr. Biol. 10, 1155-1161.
15. Canals J. M., Checa N., Marco S., Akerud P., Michels A., Perez-Navarro E., Tolosa E., Arenas E. and Alberch J. (2001) Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J. Neurosci. 21, 117-124.
16. Connor B. and Dragunow M. (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27, 1-39.
17. Diaz J., Levesque D., Lammers C. H., Griffon N., Martres M. P., Schwartz J. C. and Sokoloff P. (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65, 731-745.
18. Erlander M. G., Tillakaratne N. J., Feldblum S., Patel N. and Tobin A. J. (1991) Two genes encode distinct glutamate decarboxylases. Neuron 7, 91-100.
19. Fawcett J. P., Aloyz R., McLean J. H., Pareek S., Miller F. D., McPherson P. S. and Murphy R. A. (1997) Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes. J. Biol. Chem. 272, 8837-8840.
20. Fawcett J. P., Alonso-Vanegas M. A., Morris S. J., Miller F. D., Sadikot A. F. and Murphy R. A. (2000) Evidence that brain-derived neurotrophic factor from presynaptic nerve terminals regulates the phenotype of calbindin-containing neurons in the lateral septum. J. Neurosci. 20, 274-282.
21. Frim D. M., Uhler T. A., Galpem W. R., Beal M. F., Breakefield X. O. and Isacson O. (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl Acad. Sci. USA 91, 5104-5108.
22. Galpem W. R., Frim D. M., Tatter S. B., Altar C. A., Beal M. F. and Isacson O. (1996) Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant 5, 225-232.
23. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15, 285-320.
24. Goodman L. J., Valverde J., Lim F., Geschwind M. D., Federoff H. J., Geller A. I. and Hefti F. (1996) Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol. Cell Neurosci. 7, 222-238.
25. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
26. Haubensak W., Narz F., Heumann R. and Lessmann V. (1998) BDNF-GFP containing secretory granules are localized in the vicinity of synaptic junctions of cultured cortical neurons. J. Cell Sci. 111, 1483-1493.
27. Hung H. C. and Lee E. H. (1996) The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. Brain Res. Mol. Brain Res. 41, 14-26.
28. Hyman C., Hofer M., Barde Y. A., Juhasz M., Yancopoulos G. D., Squinto S. P. and Lindsay R. M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
29. Hyman C., Juhasz M., Jackson C., Wright P., Ip N. Y. and Lindsay R. M. (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335-347.
30. Klein R., Parada L. F., Coulier F. and Barbacid M. (1989) trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 8, 3701-3709.
31. Knusel B., Winslow J. W., Rosenthal A., Burton L. E., Seid D. R., Nikolics K. and Hefti F. (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl Acad Sci. USA 88, 961-965.
32. Lessmann V. (1998) Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen. Pharmacol. 31, 667-674.
33. Levivier M., Przedborski S., Bencsics C. and Kang U. J. (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15, 7810-7820,
34. Lu B. (2003) BDNF and activity-dependent synaptic modulation. Learn. Mem. 10, 86-98.
35. Martinez-Serrano A. and Bjorklund A. (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 16, 4604-4616.
36. Matarredona E. R., Santiago M., Venero J. L., Cano J. and Machado A. (2001) Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction. J. Neurochem. 76, 351-360.
37. Michael G. J. and Priestley J. V. (1996) Combined immunocytochemistry and in situ hybridization, in In Situ Hybridization Techniques for the Brain (Henderson Z., ed.), Vol. 17, pp. 111-118. John Wiley & Sons Ltd, London.
38. Mitsikostas D. D. and Sanchez del Rio M. (2001) Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res. Brain Res. Rev. 35, 20-35.
39. Moller J. C., Kruttgen A., Heymach J. V. Jr, Ghori N. and Shooter E. M. (1998) Subcellular localization of epitope-tagged neurotrophins in neuroendocrine cells. J. Neurosci. Res. 51, 463-467.
40. Mufson E. J., Kroin J. S., Liu Y. T., Sobreviela T., Penn R. D., Miller J. A. and Kordower J. H. (1996) Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons. Neuroscience 71, 179-191.
41. Mufson E. J., Kroin J. S., Sendera T. J. and Sobreviela T. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451-484.
42. Murer M. G., Boissiere F., Yan Q., Hunot S., Villares J., Faucheux B., Agid Y., Hirsch E. and Raisman-Vozari R. (1999) An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88, 1015-1032.
43. Murer M. G., Yan Q. and Raisman-Vozari R. (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol. 63, 71-124.
44. Nakao N., Brandin P., Funa K., Lindvall O. and Odin P. (1995) Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res. Dev Brain Res. 90, 92-101.
45. Numan S. and Seroogy K. B. (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295-308.
46. Patapoutian A. and Reichardt L. F. (2001) Trk receptors: mediators of neurotrophin action. Curr Opin. Neurobiol. 11, 272-280.
47. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Coordinates. Academic Press, London.
48. Perez-Navarro E., Alberch J., Neveu I. and Arenas E. (1999) Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo. Neuroscience 91, 1257-1264.
49. Radka S. F., Holst P. A., Fritsche M. and Altar C. A. (1996) Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 709, 122-301.
50. Ryan L. J. and Sanders D. J. (1994) Subthalamic nucleus and globus pallidus lesions alter activity in nigrothalamic neurons in rats. Brain Res. Bull. 34, 19-26.
51. Seroogy K. B., Lundgren K. H., Tran T. M., Guthrie K. M., Isackson P. J. and Gall C. M. (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321-334.
52. Shults C. W., Kimber T. and Altar C. A. (1995) BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. Neuroreport 6, 1109-1112. 26.
53. Siegel G. J. and Chauhan N. B. (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 33, 199-227.
54. Smith M. A., Zhang L. X., Lyons W. E. and Mamounas L. A. (1997) Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 8, 1829-1834.
55. Timmusk T., Palm K., Lendahl U. and Metsis M. (1999) Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J. Biol. Chem. 274, 1078-1084.
56. Venero J. L., Revuelta M., Cano J. and Machado A. (1997) Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: detection of oxidatively modified proteins in substantia nigra. J. Neurochem. 68, 2458-2468.
57. Venero J. L., Vizuete M. L., Revuelta M., Vargas C., Cano J. and Machado A. (2000) Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle. Exp. Neurol. 161, 38-48.
58. Venero J. L., Santiago M., Tomas-Camardiel M., Matarredona E. R., Cano J. and Machado A. (2002) DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Neuroscience 113, 857-869.
59. Volpe B. T., Wildmann J. and Altar C. A. (1998) Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience 83, 741-748.
60. Yan Q., Radeke M. J., Matheson C. R., Talvenheimo J., Welcher A. A. and Feinstein S. C. (1997) Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378, 135-157.
61. Zafra F., Hengerer B., Leibrock J., Thoenen H. and Lindholm D. (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 9, 3545-3550.